EKGAX | RSEBX | EKGAX / RSEBX | |
Total Expense Ratio | 1.47 | 1.45 | 101% |
Annual Report Gross Expense Ratio | 1.55 | 1.45 | 107% |
Fund Existence | 37 years | 11 years | - |
Gain YTD | 3.428 | 9.281 | 37% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 122M | 79.8B | 0% |
Annual Yield % from dividends | 0.17 | 0.23 | 72% |
Returns for 1 year | -2.42 | 9.34 | -26% |
Returns for 3 years | 7.99 | 31.03 | 26% |
Returns for 5 years | 5.19 | 16.78 | 31% |
Returns for 10 years | 0.87 | 43.37 | 2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PMGJX | 8.52 | 0.09 | +1.07% |
Principal MidCap Growth J | |||
FSMVX | 30.59 | 0.26 | +0.86% |
Fidelity Mid Cap Value | |||
NQCRX | 5.52 | 0.03 | +0.55% |
Nuveen Large Cap Value Opportunities I | |||
AVENX | 13.93 | -0.05 | -0.36% |
Avantis® Emerging Markets Equity G | |||
MKVCX | 16.26 | -0.06 | -0.37% |
MFS International Large Cap Value C |